OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0910-AH11         View EO 12866 Meetings	Received Date: 11/02/2021
Title: National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers
Agency/Subagency: HHS / FDA	Stage: Proposed Rule
Concluded Action: Consistent with Change	Concluded Date: 01/20/2022
Legal Deadline: Statutory	Economically Significant: No
Publication Date: 02/04/2022	Unfunded Mandates: No
Major: No	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: Yes	Small Entities Affected: Businesses
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No